These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2778115)

  • 21. Calcifications associated with basal cell carcinoma: prevalence, characteristics, and correlations.
    Slodkowska EA; Cribier B; Peltre B; Jones DM; Carlson JA
    Am J Dermatopathol; 2010 Aug; 32(6):557-64. PubMed ID: 20489568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Giant polypoid basal cell carcinoma with features of fibroepithelioma of Pinkus and extensive cornification.
    Misago N; Suzuki Y; Miura Y; Narisawa Y
    Eur J Dermatol; 2004; 14(4):272-5. PubMed ID: 15319165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Merkel cell carcinoma frequently shows histologic features of basal cell carcinoma: a study of 30 cases.
    Ball NJ; Tanhuanco-Kho G
    J Cutan Pathol; 2007 Aug; 34(8):612-9. PubMed ID: 17640231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma.
    Sellheyer K; Krahl D
    Br J Dermatol; 2011 Jan; 164(1):141-7. PubMed ID: 20846311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen receptor expression helps to differentiate basal cell carcinoma from benign trichoblastic tumors.
    Izikson L; Bhan A; Zembowicz A
    Am J Dermatopathol; 2005 Apr; 27(2):91-5. PubMed ID: 15798431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma.
    Evangelista MT; North JP
    J Cutan Pathol; 2015 Nov; 42(11):824-31. PubMed ID: 26016446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of dermoscopic criteria for discriminating superficial from other subtypes of basal cell carcinoma.
    Lallas A; Tzellos T; Kyrgidis A; Apalla Z; Zalaudek I; Karatolias A; Ferrara G; Piana S; Longo C; Moscarella E; Stratigos A; Argenziano G
    J Am Acad Dermatol; 2014 Feb; 70(2):303-11. PubMed ID: 24268311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
    Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
    Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morpheaform Basal Cell Carcinomas With Areas of Predominantly Single-Cell Pattern of Infiltration: Diagnostic Utility of p63 and Cytokeratin.
    East E; Fullen DR; Arps D; Patel RM; Palanisamy N; Carskadon S; Harms PW
    Am J Dermatopathol; 2016 Oct; 38(10):744-50. PubMed ID: 27043336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Basalioma].
    Diem E
    Ther Umsch; 1993 Dec; 50(12):812-6. PubMed ID: 8171402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Not Available].
    Cribier B
    Ann Dermatol Venereol; 2018 Nov; 145 Suppl 5():VS3-VS11. PubMed ID: 30477681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation between basal cell carcinoma and trichoepithelioma by immunohistochemical staining of the androgen receptor: an overview.
    Arits AH; Van Marion AM; Lohman BG; Thissen MR; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Eur J Dermatol; 2011; 21(6):870-3. PubMed ID: 21865121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basal cell carcinoma in association with multiple trichoepitheliomas.
    Misago N; Narisawa Y
    Dermatology; 2001; 202(3):261-5. PubMed ID: 11385237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
    Gaballah MA; Ahmed RA
    Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two Novel Biomarker Candidates for Differentiating Basal Cell Carcinoma from Trichoblastoma; Asprosin and Meteorine Like Peptide.
    Kocaman N; Yuksel EI; Demir B; Calik I; Cicek D
    Tissue Cell; 2022 Jun; 76():101752. PubMed ID: 35144124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dermatoscopic features of pigmented and non-pigmented basal cell carcinoma.
    Kiladze N; Shulaia T; Bulinska A; Abrahamovych L
    Georgian Med News; 2015 Jan; (238):50-3. PubMed ID: 25693214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas.
    Smoller BR; Van de Rijn M; Lebrun D; Warnke RA
    Br J Dermatol; 1994 Jul; 131(1):28-31. PubMed ID: 8043419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of androgen receptor by fibroepithelioma of Pinkus: evidence supporting classification as a basal cell carcinoma variant?
    Katona TM; Ravis SM; Perkins SM; Moores WB; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):7-12. PubMed ID: 17284955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
    Sellheyer K; Nelson P; Kutzner H; Patel RM
    J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scaly pink patches: differentiating psoriasis from basal cell carcinoma.
    Hanna C; Cook L; Foulke G; Seiverling EV
    Cutis; 2018 Jan; 101(1):44-46. PubMed ID: 29529103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.